A Japanese case of severe refractory adult Still's disease: serum interleukin-18 is a possible marker of the response to low-dose cyclosporin A therapy.

Yasunori Sawayama, Shigeki Nabeshima, Hiroaki Taniai, Norihiro Furusyo, Seizaburo Kashiwagi, Jun Hayashi

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint

Dive into the research topics of 'A Japanese case of severe refractory adult Still's disease: serum interleukin-18 is a possible marker of the response to low-dose cyclosporin A therapy.'. Together they form a unique fingerprint.

Medicine & Life Sciences